Union Donepezil Tablets 23 mg (Donepezil Hydrochloride Hydrate)
Donepezil Hydrochloride Hydrate 24mg
Tablet · Prescription medication
Korea Union Pharmaceutical Co., Ltd.
MFDS item code 202102969 · Approved 2021.04.07
Treatment of symptoms of moderate to severe Alzheimer’s-type dementia
This medication is used for the treatment of symptoms of moderate to severe Alzheimer's-type dementia. It helps improve the patient's memory decline and cognitive dysfunction, thereby enhancing the quality of daily life. Continuous use can contribute to delaying the progression of symptoms and maintaining a stable condition. This medication protects the patient's cognitive function and assists in providing a better living environment.
Take this medicine once daily in the evening, immediately before bedtime, with or without food. If sleep disturbances such as unusual dreams, nightmares, or insomnia occur, consider taking this medicine in the morning. Do not split, crush, or chew this medicine, as this may increase the rate of absorption. The recommended initial dose of donepezil hydrochloride is 5mg once daily. This medicine reaches steady state 15 days after administration, and the incidence of adverse reactions may be affected by the rate of dose escalation; therefore, administer 5mg for 4 ~ 6 weeks. After evaluating the clinical response during this period, the dose may be increased to 10mg. When increasing the dose to 10mg daily, administer with caution for gastrointestinal adverse reactions. A dose of 23mg once daily may be administered to patients who have taken 10mg once daily for at least 3 months.
This medication contains Donepezil Hydrochloride Hydrate as the active ingredient and is used for the treatment of Alzheimer's-type dementia symptoms. This medication should not be given to certain patients. For example, individuals allergic to this medication or its components, women who are pregnant or may become pregnant, and those with lactose intolerance or inherited lactose metabolism disorders should not take this medication. Patients with heart diseases or heart conduction disorders should be cautious when taking this medication as bradycardia or arrhythmia may occur. Patients taking non-steroidal anti-inflammatory analgesics or have a history of peptic ulcers should be careful as symptoms may worsen due to increased gastric acid secretion and enhanced gastrointestinal motility. Patients with asthma or obstructive pulmonary disease should also be cautious, as bronchoconstriction and increased mucus secretion may worsen symptoms. Patients with extrapyramidal disorders, such as Parkinson's disease, may experience worsening of motor symptoms from this medication. Additionally, this medication contains Tartrazine (Yellow No. 4), and those allergic or sensitive to this ingredient should be cautious. Various adverse reactions may occur while taking this medication, such as fainting, bradycardia, heart block, gastrointestinal bleeding, liver dysfunction, cerebrovascular disorders, and movement disorders in severe cases. Mild adverse reactions may frequently include nausea, vomiting, diarrhea, loss of appetite, dizziness, insomnia, headaches, and fatigue. The occurrence of adverse reactions may increase, particularly at high doses, so patients should be closely monitored when increasing the dosage. This medication is not approved for other forms of memory disorders besides dementia, and treatment should be conducted under the supervision of a physician experienced in this area. This medication can affect heart conduction, so patients with heart diseases require monitoring, including an electrocardiogram. It is recommended that women who are pregnant or breastfeeding do not use this medication. This medication can interact with various drugs, so if other medications are being taken, consult a physician or pharmacist. In case of overdose, serious symptoms such as nausea, vomiting, bradycardia, and respiratory depression may occur, requiring immediate medical attention, and Atropine can be used as an antidote. This medication should be kept out of reach of children, and transferring it to other containers is discouraged to maintain quality.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air exposure and ideally kept at room temperature between 1°C and 30°C. Proper storage will help maintain the medication's effectiveness and prevent deterioration.
Red, biconvex, round film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Donepezil Hydrochloride Hydrate 24mg
Tablet · Prescription medication
Korea Union Pharmaceutical Co., Ltd.

Donepezil Hydrochloride 5mg
Tablet · Prescription medication
HanDoc Co., Ltd.

Donepezil Hydrochloride 10mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Yuhan Corporation

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Myungmoon Pharmaceutical Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Donepezil Hydrochloride 10mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.